Resultados de la búsqueda 141-150 of 7445 for ���������������������������������TALK:PC53���

1. Neurología - Ensayos clínicos - Mayo Clinic

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

2. Neurología - Ensayos clínicos - Mayo Clinic

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

3. Neurología - Ensayos clínicos - Mayo Clinic

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

4. Deficiencia de alfa-1 antitripsina - Síntomas y causas - Mayo Clinic

   If you or your child has symptoms of lung, liver, skin or blood vessel disease, talk with your healthcare professional about testing for the condition. Talk ...

5. Neurología - Ensayos clínicos - Mayo Clinic

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

6. Prostate cancer recurrence

   Learn as much as you need to know about recurrent prostate cancer and its treatment to feel comfortable talking about your options with your healthcare team.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

8. Ensayos clínicos - Neurología

   We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant speech and language domains and to ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...